NCT05091619View on ClinicalTrials.gov

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

2,898

Participants

Timeline

Start Date

October 22, 2021

Primary Completion Date

January 22, 2024

Study Completion Date

September 22, 2027

Conditions
Whooping CoughDiphtheriaTetanus
Interventions
BIOLOGICAL

Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed

Intramuscular injection

BIOLOGICAL

Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed

Intramuscular injection

BIOLOGICAL

Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed) and Haemophilus influenzae type b conjugate vaccine

Intramuscular injection

Trial Locations (4)

453200

Yanjin County Center for Disease Control and Prevention, Xinxiang

454850

Wen County Center for Disease Control and Prevention, Jiaozuo

456300

Neihuang County Center for Disease Control and Prevention, Anyang

462400

Wuyang County Center for Disease Control and Prevention, Luohe

All Listed Sponsors
collaborator

Beijing Institute of Biological Products Co Ltd.

INDUSTRY

lead

China National Biotec Group Company Limited

INDUSTRY